The Hereditary Disease Foundation (HDF), which funds scientific research to find treatments and cures for Huntington’s disease, has named Barry H. Evenchick Chief Counsel. Mr. Evenchick is a partner at the New Jersey-based law firm Pashman Stein Walder Hayden where his practice focuses on litigation.
Mr. Evenchick is a former prosecutor, having served as chief of the appellate section of the Essex County Prosecutor’s Office and as the first chief of the appellate section of the New Jersey Division of Criminal Justice. He also served for 12 years as the municipal attorney of the Township of Livingston and for six years as a commissioner of the New Jersey State Commission of Investigation. He is an adjunct faculty member of Rutgers Law School in Newark and serves as vice-chair of the editorial board of the New Jersey Law Journal. He is a member of the HDF Board of Directors.
“We are privileged to have Mr. Evenchick’s expertise as we ramp up our funding of innovative research into treatments for Huntington’s disease. I look forward to working with him in his new capacity as Chief Counsel,” said Meghan Donaldson, CEO of the Hereditary Disease Foundation.
Mr. Evenchick said, “It is a particular honor to be named Chief Counsel at this time when the Hereditary Disease Foundation has just launched the Nancy S. Wexler Discovery Fund and named the first recipient of the Nancy S. Wexler Young Investigator Prize. This is an exciting period as we expand our efforts to support research that is making a difference in the lives of Huntington’s disease patients and their families.”
About the Hereditary Disease Foundation
The Hereditary Disease Foundation facilitates collaborative and innovative scientific research to further the understanding of Huntington’s disease, a genetic disorder that strikes in early- to mid-adulthood, destroying brain cells and bringing on severe and progressive declines in personality, cognitive ability, and mobility. As a disease caused by a mistake on a single gene, Huntington’s disease is an ideal model for other brain disorders. Research organized by the Foundation led to the discovery of the genetic marker for Huntington’s disease in 1983. HDF organized and funded a decade-long international collaboration of over 100 scientists who discovered the gene that causes Huntington’s in 1993. This work played an important role in the development of the Human Genome Project. For information, visit http://www.hdfoundation.org.